Sign In
Buy JAZZ
$252.86
-5.52 (-2.14%)
At Close: Jul 31, 2026
IDEAYA Biosciences Announces Addition of Julie Patel as Vice President, Human Resources, Enhancing its Leadership Team
10:00am, Tuesday, 21'st Apr 2020
IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecu
Emergent BioSolutions appoints Karen Smith as CMO EBS;JAZZ
09:58am, Tuesday, 21'st Apr 2020
Emergent BioSolutions appoints Karen Smith as CMO EBS JAZZ
Cardinal Capital Management Acquires Shares of 4,443 Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
09:14am, Tuesday, 21'st Apr 2020
Cardinal Capital Management bought a new position in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) during the first quarter, according to its most recent disclosure with the Securities & Exchange C
Assenagon Asset Management S.A. Trims Position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
08:42am, Tuesday, 21'st Apr 2020
Assenagon Asset Management S.A. decreased its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) by 83.9% during the first quarter, according to its most recent filing with the SEC. The firm
Henry Grimes, free jazz legend, dead at 84 of coronavirus complications
01:01pm, Monday, 20'th Apr 2020
Henry Grimes, the multi-instrumentalist whose career in jazz music spanned more than 60 years, has died of complications related to the coronavirus. He was 84. His wife Margaret Davis Grimes confir…
$540.98 Million in Sales Expected for Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) This Quarter
07:38am, Monday, 20'th Apr 2020
Equities analysts expect Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) to announce $540.98 million in sales for the current quarter, Zacks reports. Seven analysts have made estimates for Jazz Pharmaceuticals
Brokers Offer Predictions for Jazz Pharmaceuticals PLC's Q2 2020 Earnings (NASDAQ:JAZZ)
06:18am, Monday, 20'th Apr 2020
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) – Research analysts at Oppenheimer lowered their Q2 2020 earnings per share estimates for Jazz Pharmaceuticals in a research note issued to investors on Thursd
Cardinal Capital Management Buys Truist Financial Corp, VMware Inc, Jazz Pharmaceuticals PLC, ...
12:00am, Monday, 20'th Apr 2020Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Position Increased by CENTRAL TRUST Co
10:40am, Sunday, 19'th Apr 2020
CENTRAL TRUST Co raised its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) by 25.2% in the 1st quarter, Holdings Channel reports. The firm owned 13,356 shares of the specialty pharmaceut
Free jazz legend Giuseppi Logan dead of coronavirus at 84
12:17am, Sunday, 19'th Apr 2020
Jazz legend Giuseppi Logan died of the coronavirus at a Far Rockaway nursing home, according to a report. He was 84. Logan, who became an icon in New York’s free jazz movement in the 1960s, died at�
Zacks: Analysts Anticipate Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Will Announce Earnings of $0.62 Per Share
10:32am, Saturday, 18'th Apr 2020
Analysts expect Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) to post $0.62 earnings per share (EPS) for the current quarter, Zacks reports. Seven analysts have issued estimates for Jazz Pharmaceuticals’ e
Introducing Jazz Pharmaceuticals (NASDAQ:JAZZ), The Stock That Dropped 43% In The Last Five Years
06:16pm, Friday, 17'th Apr 2020
Ideally, your overall portfolio should beat the market average. But every investor is virtually certain to have both...
FY2022 EPS Estimates for Jazz Pharmaceuticals PLC Cut by SVB Leerink (NASDAQ:JAZZ)
08:14am, Friday, 17'th Apr 2020
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) – Equities researchers at SVB Leerink dropped their FY2022 earnings estimates for shares of Jazz Pharmaceuticals in a note issued to investors on Monday, April
Jazz Pharmaceuticals (JAZZ) Received its Third Buy in a Row
07:01am, Friday, 17'th Apr 2020
After Merrill Lynch and RBC Capital gave Jazz Pharmaceuticals (NASDAQ: JAZZ) a Buy rating last month, the company received another Buy, this time from
Jazz Pharmaceuticals (JAZZ) Received its Third Buy in a Row
07:00am, Friday, 17'th Apr 2020
After Merrill Lynch and RBC Capital gave Jazz Pharmaceuticals (NASDAQ: JAZZ) a Buy rating last month, the company received another
